A new trading day began on Monday, with Wave Life Sciences Ltd (NASDAQ: WVE) stock price up 6.19% from the previous day of trading, before settling in for the closing price of $5.65. WVE’s price has ranged from $4.25 to $16.74 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 607.85% over the past five years. Meanwhile, its annual earnings per share averaged -37.40%. With a float of $122.54 million, this company’s outstanding shares have now reached $153.04 million.
Let’s look at the performance matrix of the company that is accounted for 288 employees. In terms of profitability, gross margin is 60.69%, operating margin of -101.94%, and the pretax margin is -89.57%.
Wave Life Sciences Ltd (WVE) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Wave Life Sciences Ltd is 20.16%, while institutional ownership is 79.54%. The most recent insider transaction that took place on Mar 20 ’25, was worth 102,574. In this transaction Director of this company sold 10,500 shares at a rate of $9.77, taking the stock ownership to the 16,115 shares. Before that another transaction happened on Mar 20 ’25, when Company’s Director proposed sale 10,500 for $9.77, making the entire transaction worth $102,579.
Wave Life Sciences Ltd (WVE) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.25 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -37.40% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 0.13% during the next five years compared to 34.27% growth over the previous five years of trading.
Wave Life Sciences Ltd (NASDAQ: WVE) Trading Performance Indicators
Here are Wave Life Sciences Ltd’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 2.89. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 8.50.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.79, a number that is poised to hit -0.25 in the next quarter and is forecasted to reach -1.02 in one year’s time.
Technical Analysis of Wave Life Sciences Ltd (WVE)
Wave Life Sciences Ltd (NASDAQ: WVE) saw its 5-day average volume 1.57 million, a positive change from its year-to-date volume of 1.16 million. As of the previous 9 days, the stock’s Stochastic %D was 14.96%. Additionally, its Average True Range was 0.73.
During the past 100 days, Wave Life Sciences Ltd’s (WVE) raw stochastic average was set at 6.48%, which indicates a significant decrease from 12.79% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 105.20% in the past 14 days, which was higher than the 75.32% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $9.58, while its 200-day Moving Average is $9.83. Nevertheless, the first resistance level for the watch stands at $6.14 in the near term. At $6.29, the stock is likely to face the second major resistance level. The third major resistance level sits at $6.52. If the price goes on to break the first support level at $5.76, it is likely to go to the next support level at $5.53. The third support level lies at $5.38 if the price breaches the second support level.
Wave Life Sciences Ltd (NASDAQ: WVE) Key Stats
With a market capitalization of 920.94 million, the company has a total of 153,486K Shares Outstanding. Currently, annual sales are 108,300 K while annual income is -97,010 K. The company’s previous quarter sales were 83,750 K while its latest quarter income was 29,250 K.
